Patterns of pseudoprogression across different cancer entities treated with immune checkpoint inhibitors

Patterns of pseudoprogression across different cancer entities treated with immune checkpoint inhibitors

Abstract Background Pseudoprogression (PsPD) is a rare response pattern to immune checkpoint inhibitor (ICI) therapy in oncology. This study aims to reveal imaging features of PsPD, and their association to other relevant findings. Methods Patients with PsPD who had at least three consecutive cross-...

Full description

Bibliographic Details
Main Authors: Sebastian Mönch, Maurice M. Heimer, Michael Winkelmann, Anne Guertler, Max Schlaak, Amanda Tufman, Najib Ben Khaled, Enrico de Toni, Christoph B. Westphalen, Michael von Bergwelt-Baildon, Julien Dinkel, Philipp M. Kazmierczak, Michael Ingrisch, Nabeel Mansour, Marcus Unterrainer, Lucie Heinzerling, Jens Ricke, Wolfgang G. Kunz
Format: Article
Language:English
Published: BMC 2023-06-01
Series:Cancer Imaging
Subjects:
Immune Checkpoint inhibitors
Pseudoprogression
Cancer
Atypical response patterns
Immune related adverse events
Online Access:https://doi.org/10.1186/s40644-023-00580-9

Internet

https://doi.org/10.1186/s40644-023-00580-9

Similar Items